Jiangsu Recbio Technology Co., Ltd., commonly referred to as Recbio, is a leading biotechnology firm headquartered in Jiangsu, China. Founded in 2016, the company has rapidly established itself in the biopharmaceutical industry, focusing on innovative vaccine development and advanced therapeutic solutions. Recbio's core offerings include recombinant protein vaccines and other biologics, distinguished by their cutting-edge technology and commitment to safety and efficacy. The company has achieved significant milestones, including successful clinical trials and partnerships that enhance its market presence. With a strong emphasis on research and development, Recbio is well-positioned in the competitive landscape of vaccine production, contributing to global health initiatives and addressing unmet medical needs. Its dedication to innovation and quality has garnered recognition within the industry, solidifying its reputation as a key player in the biotechnology sector.
How does Jiangsu Recbio Technology Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Jiangsu Recbio Technology Co's score of 2 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2021, Jiangsu Recbio Technology Co, headquartered in China, reported total carbon emissions of approximately 5,067,020 kg CO2e. Notably, all of these emissions fall under Scope 2, which pertains to indirect emissions from purchased electricity, steam, heating, and cooling. The company has not disclosed any specific reduction targets or initiatives aimed at decreasing its carbon footprint, nor has it made any climate pledges. With a revenue of about USD 948,868, Jiangsu Recbio's greenhouse gas emission intensity was reported at 190.0 kg CO2e per square metre. As the company continues to operate within the biotechnology sector, it is essential for them to consider future commitments to sustainability and emissions reduction in line with industry standards.
Access structured emissions data, company-specific emission factors, and source documents
Add to project2021 | |
---|---|
Scope 1 | - |
Scope 2 | 5,067,020 |
Scope 3 | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jiangsu Recbio Technology Co is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.